Literature DB >> 23606572

Meta-analysis of association between obsessive-compulsive disorder and the 3' region of neuronal glutamate transporter gene SLC1A1.

S E Stewart1, C Mayerfeld, P D Arnold, J R Crane, C O'Dushlaine, J A Fagerness, D Yu, J M Scharf, E Chan, F Kassam, P R Moya, J R Wendland, R Delorme, M A Richter, J L Kennedy, J Veenstra-VanderWeele, J Samuels, B D Greenberg, J T McCracken, J A Knowles, A J Fyer, S L Rauch, M A Riddle, M A Grados, O J Bienvenu, B Cullen, Y Wang, Y Y Shugart, J Piacentini, S Rasmussen, G Nestadt, D L Murphy, M A Jenike, E H Cook, D L Pauls, G L Hanna, C A Mathews.   

Abstract

The neuronal glutamate transporter gene SLC1A1 is a candidate gene for obsessive-compulsive disorder (OCD) based on linkage studies and convergent evidence implicating glutamate in OCD etiology. The 3' end of SLC1A1 is the only genomic region with consistently demonstrated OCD association, especially when analyzing male-only probands. However, specific allele associations have not been consistently replicated, and recent OCD genome-wide association and meta-analysis studies have not incorporated all previously associated SLC1A1 SNPs. To clarify the nature of association between SLC1A1 and OCD, pooled analysis was performed on all available relevant raw study data, comprising a final sample of 815 trios, 306 cases and 634 controls. This revealed weak association between OCD and one of nine tested SLC1A1 polymorphisms (rs301443; uncorrected P = 0.046; non-significant corrected P). Secondary analyses of male-affecteds only (N = 358 trios and 133 cases) demonstrated modest association between OCD and a different SNP (rs12682807; uncorrected P = 0.012; non-significant corrected P). Findings of this meta-analysis are consistent with the trend of previous candidate gene studies in psychiatry and do not clarify the putative role of SLC1A1 in OCD pathophysiology. Nonetheless, it may be important to further examine the potential associations demonstrated in this amalgamated sample, especially since the SNPs with modest associations were not included in the more highly powered recent GWAS or in a past meta-analysis including five SLC1A1 polymorphisms. This study underscores the need for much larger sample sizes in future genetic association studies and suggests that next-generation sequencing may be beneficial in examining the potential role of rare variants in OCD.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23606572     DOI: 10.1002/ajmg.b.32137

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  37 in total

Review 1.  Pharmacological treatment of obsessive-compulsive disorder.

Authors:  Christopher Pittenger; Michael H Bloch
Journal:  Psychiatr Clin North Am       Date:  2014-07-24

2.  Behavioral and synaptic alterations relevant to obsessive-compulsive disorder in mice with increased EAAT3 expression.

Authors:  Claudia Delgado-Acevedo; Sebastián F Estay; Anna K Radke; Ayesha Sengupta; Angélica P Escobar; Francisca Henríquez-Belmar; Cristopher A Reyes; Valentina Haro-Acuña; Elías Utreras; Ramón Sotomayor-Zárate; Andrew Cho; Jens R Wendland; Ashok B Kulkarni; Andrew Holmes; Dennis L Murphy; Andrés E Chávez; Pablo R Moya
Journal:  Neuropsychopharmacology       Date:  2018-12-26       Impact factor: 7.853

3.  OCD candidate gene SLC1A1/EAAT3 impacts basal ganglia-mediated activity and stereotypic behavior.

Authors:  Isaac D Zike; Muhammad O Chohan; Jared M Kopelman; Emily N Krasnow; Daniel Flicker; Katherine M Nautiyal; Michael Bubser; Christoph Kellendonk; Carrie K Jones; Gregg Stanwood; Kenji Fransis Tanaka; Holly Moore; Susanne E Ahmari; Jeremy Veenstra-VanderWeele
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-15       Impact factor: 11.205

Review 4.  Obsessive-compulsive disorder: an integrative genetic and neurobiological perspective.

Authors:  David L Pauls; Amitai Abramovitch; Scott L Rauch; Daniel A Geller
Journal:  Nat Rev Neurosci       Date:  2014-06       Impact factor: 34.870

Review 5.  Genetics of obsessive-compulsive disorder and related disorders.

Authors:  Heidi A Browne; Shannon L Gair; Jeremiah M Scharf; Dorothy E Grice
Journal:  Psychiatr Clin North Am       Date:  2014-07-23

6.  Significant concordance of genetic variation that increases both the risk for obsessive-compulsive disorder and the volumes of the nucleus accumbens and putamen.

Authors:  Derrek P Hibar; Joshua W Cheung; Sarah E Medland; Mary S Mufford; Neda Jahanshad; Shareefa Dalvie; Raj Ramesar; Evelyn Stewart; Odile A van den Heuvel; David L Pauls; James A Knowles; Dan J Stein; Paul M Thompson
Journal:  Br J Psychiatry       Date:  2018-07       Impact factor: 9.319

Review 7.  Rodent models of obsessive compulsive disorder: Evaluating validity to interpret emerging neurobiology.

Authors:  Isaac Zike; Tim Xu; Natalie Hong; Jeremy Veenstra-VanderWeele
Journal:  Neuroscience       Date:  2016-09-16       Impact factor: 3.590

8.  Neuronal excitatory amino acid transporter EAAT3: Emerging functions in health and disease.

Authors:  Suzanne M Underhill; Susan L Ingram; Susanne E Ahmari; Jeremy Veenstra-VanderWeele; Susan G Amara
Journal:  Neurochem Int       Date:  2018-05-22       Impact factor: 3.921

Review 9.  Obsessive-compulsive disorder.

Authors:  Dan J Stein; Daniel L C Costa; Christine Lochner; Euripedes C Miguel; Y C Janardhan Reddy; Roseli G Shavitt; Odile A van den Heuvel; H Blair Simpson
Journal:  Nat Rev Dis Primers       Date:  2019-08-01       Impact factor: 52.329

10.  Riluzole augmentation in treatment-refractory obsessive-compulsive disorder: a pilot randomized placebo-controlled trial.

Authors:  Christopher Pittenger; Michael H Bloch; Suzanne Wasylink; Eileen Billingslea; Ryan Simpson; Ewgeni Jakubovski; Ben Kelmendi; Gerard Sanacora; Vladimir Coric
Journal:  J Clin Psychiatry       Date:  2015-08       Impact factor: 4.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.